Interestingly, the levels of both UCHL1 and FABP3 significantly increased already in pre-AD patients compared with SCD and MCI, indicating that these changes are present in cognitively unimpaired patients with a positive CSF profile for the core AD biomarkers. The gene discussed is UCHL1; the disease is Alzheimer disease.